BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2507611)

  • 1. Coronary thrombolysis and the new biology.
    Sobel BE
    J Am Coll Cardiol; 1989 Oct; 14(4):850-60. PubMed ID: 2507611
    [No Abstract]   [Full Text] [Related]  

  • 2. The promise of new genetically engineered plasminogen activators.
    Cutler D; Bode C; Runge MS
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):3S-7S. PubMed ID: 8770835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombolytic therapy].
    Matsuda T
    Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the improvement of thrombolytic agents.
    Lijnen HR; Collen D
    Thromb Haemost; 1991 Jul; 66(1):88-110. PubMed ID: 1926054
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 6. Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation.
    Davis SM; Donnan GA
    Stroke; 2005 May; 36(5):1106-7. PubMed ID: 15802638
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolysis: Reteplase as an innovative alternative].
    Z Kardiol; 1997 Oct; 86(10 Suppl):1-4. PubMed ID: 9403093
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
    Haskel EJ; Prager NA; Sobel BE; Abendschein DR
    Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.
    Fitzgerald DJ; Wright F; FitzGerald GA
    Circ Res; 1989 Jul; 65(1):83-94. PubMed ID: 2500270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis. An approach still on the move.
    Verstraete M
    Drugs; 1989 Feb; 37(2):116-22. PubMed ID: 2495217
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary thrombolysis.
    Cairns JA; Fuster V; Gore J; Kennedy JW
    Chest; 1995 Oct; 108(4 Suppl):401S-423S. PubMed ID: 7555192
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
    Sherry S
    Am J Cardiol; 1987 Apr; 59(9):984-9. PubMed ID: 3105303
    [No Abstract]   [Full Text] [Related]  

  • 15. Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets.
    Prager NA; Torr-Brown SR; Sobel BE; Abendschein DR
    J Am Coll Cardiol; 1993 Jul; 22(1):296-301. PubMed ID: 8509554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet effects of fibrinolytic agents: a potential contributor to the hemostatic defect after thrombolysis.
    Kamat SG; Schafer AI
    Coron Artery Dis; 1995 Dec; 6(12):930-5. PubMed ID: 8723014
    [No Abstract]   [Full Text] [Related]  

  • 18. The coming competition among clot-busting drugs.
    Sun M
    Science; 1988 Jun; 240(4857):1267-9. PubMed ID: 3131878
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacology of coronary thrombolysis.
    Tiefenbrunn AI; Robison AK; Sobel BE
    Cardiol Clin; 1987 Feb; 5(1):125-8. PubMed ID: 3103917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute stroke treatment: thrombolysis.
    Bogousslavsky J; Paciaroni M; Gallai V
    Cerebrovasc Dis; 2000; 10 Suppl 4():14-6. PubMed ID: 11070393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.